Macrophages as Potential Therapeutic Targets in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a heterogenous malignant hemopathy, and although new drugs have emerged recently, current treatment options still show limited efficacy.Therapy resistance remains a major concern due to its contribution to treatment failure, disease relapse, and increased mortality among patients.The underlying mechanisms of resistan